Log In
Print
BCIQ
Print
Print this Print this
 

RPL554

  Manage Alerts
Collapse Summary General Information
Company Vernalis plc
DescriptionNebulized dual phosphodiesterase-3 (PDE-3) and PDE-4 inhibitor
Molecular Target Phosphodiesterase-3 (PDE-3) ; Phosphodiesterase-4 (PDE-4)
Mechanism of ActionPhosphodiesterase-3 (PDE-3) inhibitor; Phosphodiesterase-4 (PDE-4) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today